↑ Read the latest from the desks · fresh intelligence, published daily✦Quiet reading✦No ads, ever✦Ad-free articles read by humans today …↑✦Boards engagement today … people · … AI✦Corporate brand & media services✦Made in Virginia Beach since 1997✦
Trulieve$TRLV · filed: saw revenue fall 0.4% in FY2025 to $1.2BSound shipTrillion Score 455Fall Risk MediumNext year $957M–$1.4B sealedCheck ▾Close ▴
What Trulieve filed
Saw revenue fall 0.4% in FY2025 to $1.2 billion, operating margin 12.1% against a 0.7% median for medicinal chemicals & botanical products, equity 42.4% of assets. Every figure links to the filing it came from on Trulieve’s card. Sound ship: one warning sign. Trillion Score 455, #130 of 182 in its field; Fall Risk Medium (how it is measured).
What the house said in advance
Revenue for the fiscal year after 2025-12-31 between $957M and $1.4B, an 80% range sealed on 27 Sept 2026 · receipt #5f33c4 · graded in public by the revenue in Trulieve’s next annual report.
Figures as filed with the SEC. Ranges, scores and boats are statistical descriptions of past filings, not ratings or recommendations. Reporting, not advice.
In plain words
Trulieve's buyback signals the widening divide between cash-generative MSOs and capital-starved peers as federal delays extend consolidation windows.
$900 million-plus
revenue runs are treating buybacks as viable capital allocation…
70%
of Florida's medical dispensary footprint and generates roughly
$1.3 billion
in trailing-twelve-month revenue
82%
of sector EBITDA in the most recent quarter
Trulieve Cannabis Corp. authorized a new share repurchase program this week, the latest sign that U.S. medical cannabis operators with $900 million-plus revenue runs are treating buybacks as viable capital allocation while federal rescheduling timelines stretch and micro-cap competitors bleed working capital. The company did not disclose authorization size or expected pace, but the announcement arrives as Trulieve holds approximately 70% of Florida's medical dispensary footprint and generates roughly $1.3 billion in trailing-twelve-month revenue.
The move follows a twelve-month period in which five mid-tier U.S. multi-state operators filed for bankruptcy protection or executed distressed asset sales, while Trulieve and three peer MSOs — Curaleaf, Green Thumb Industries, Verano — captured 82% of sector EBITDA in the most recent quarter. Share repurchases remain rare among U.S. cannabis operators, most of which carry net debt-to-EBITDA ratios above 3.5x and face annualized interest expenses exceeding 12% on non-bank credit facilities. Trulieve's authorization suggests management expects free cash flow generation to sustain through at least mid-2026, even if federal Schedule III reclassification delays into late 2025 or early 2026.
What matters for allocators: the repurchase program functions as a structural short against smaller MSOs whose survival depends on near-term regulatory catalysts. Trulieve's Florida dominance generates 28-31% EBITDA margins, insulating the company from the price compression now visible in Arizona, Illinois, and Michigan markets where dispensary counts rose 40-60% since 2022. The authorization also clarifies that Trulieve expects no large M&A deployment in the next six to nine months, effectively pausing consolidation activity at the top tier while distressed assets accumulate at the bottom. That pause creates a two-stage setup: Trulieve returns capital now, then deploys cash into distressed acquisitions once bankruptcy courts clear 2025 filings. Family offices and fund managers tracking the sector should note that MSOs with quarterly free cash conversion below 15% now face a three-quarter window to secure bridge financing or initiate strategic processes before lender covenants tighten in Q1 2026.
Operators and allocators should watch three follow-on events. First, whether Trulieve executes buybacks on the Canadian Securities Exchange or OTC Markets, signaling whether the company prioritizes retail sentiment or insider/institutional liquidity. Second, Q4 2024 earnings in late February will clarify whether the authorization reflects confidence in sustained $80-90 million quarterly free cash flow or temporary balance sheet strength before a capex cycle. Third, any federal rescheduling commentary from the DEA or HHS between now and March 2025 will determine whether Trulieve accelerates or suspends the program, as Schedule III treatment would reduce effective tax rates by 15-20 percentage points and unlock EBITDA for either buybacks or acquisitions.
The program arrives thirty-one months after Trulieve's last significant capital return event, a $100 million debt paydown in mid-2022. The company's shares trade at approximately 4.2x forward EBITDA, a 30-40% discount to Canadian licensed producers and a 50-60% discount to beverage-adjacent cannabis plays, despite superior margins and domestic regulatory tailwinds. The discount persists because U.S. MSOs remain locked out of major exchanges and institutional allocators, but that gap is the point: Trulieve is buying at trough multiples with monopoly-grade cash flows.
Branded by POPS4 · proof in 60 seconds
For the principal
Track whether Trulieve accelerates buybacks if DEA rescheduling delays past Q2 2025, creating distressed M&A opportunities at the micro-cap tier.
Named accounts with U.S. MSO exposure should overweight cash-generative operators; Trulieve buyback confirms our thesis on margin divergence through 2025.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.
